Trinean Signs a Global Agreement with Bayer CropScience
News Jun 12, 2013
Trinean it has entered into a long-term agreement with Bayer CropScience to supply DropSense96 and Xpose droplet readers along with its proprietary cDrop spectral analysis software to Bayer CropScience's global operations. Bayer CropScience will be using Trineans technology for High Throughput quantification and quality control of isolated biomolecules to assure robust outcome of genetic tests in its molecular breeding program.
“Trinean is delighted to be a global supplier to Bayer CropScience. Our microfluidic technology matches the expectations of Bayer CropScience in terms of automation, minimal sample consumption and accurate quantification of a broad range of plant extracts.” said Yvan Sergeant, VP commercial operations of Trinean. “We are committed to helping Bayer CropScience reach its high standards in the genetic research and high-quality seeds for field and vegetable crops.”
A real challenge exists for all plant genetic labs to accurately quantify nucleic acid extracts from plant tissue due to variations in genome size and the presence of co-purified buffer components or plant metabolites influencing both the quantification result as well as downstream genetic tests. Unlike traditional methods, the Trinean technology performs an in-depth sample content analysis by profiling the measured UV/VIS absorbance spectrum for both the biomolecule of interest and interfering chemicals. This approach allows specific concentration determination and genuine purity analysis within a simple ‘drop & read’ approach.
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018